← Open Payments lookup

INNA ZELTSER: Open Payments

NPI 1346675717 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,635 in 60 payments from 12 companies in 2025. Trend: 2023 $370 · 2024 $1,446 · 2025 $1,635

Food & beverage: $1,635
CompanyPaymentsAmount
Ardelyx, Inc.14$355
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$272
Aimmune Therapeutics, Inc.6$252
Janssen Biotech, Inc.8$213
Madrigal Pharmaceuticals6$192
ABBVIE INC.9$172
Phathom Pharmaceuticals, Inc.2$58
Takeda Pharmaceuticals U.S.A., Inc.1$27
Boston Scientific Corporation1$26
Ipsen Biopharmaceuticals, Inc1$24

Products named: IBSRELA, XIFAXAN, ZENPEP, TREMFYA, REZDIFFRA, LINZESS, VOQUEZNA, RINVOQ.

Industry payments across NY — which companies pay providers there.